Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-068040

Aimmune Therapeutics, Inc. · AIMT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 24, 2015
Accepted (ET)
Aug 26, 2015 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631650

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par valueF2Aug 24, 2015P25,485$19.6547A355,020ISee Footnote
Common Stock, $0.0001 par valueF1holding———4,087,900ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses